Lysosomal Storage Disorder Therapeutics Pipeline has Maximum Drugs Being Developed as Gene Therapy: P&S Market Research NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- According to the market research report published by P&S Market Research, the study analyzed that the lysosomal storage disorder therapeutics pipeline...

Acute Kidney Injury (AKI) Therapeutics Pipeline to Witness an Increase in the Number of Patent Approvals: P&S Market Research NEW YORK, March 20, 2018 (GLOBE NEWSWIRE) -- According to a new research report titled “Acute Kidney Injury (AKI) Therapeutics - Pipeline Analysis 2018” published by P&S Market Research, AKI...